Literature DB >> 23547052

Apc regulates the function of hematopoietic stem cells largely through β-catenin-dependent mechanisms.

Wenshu Li1, Yu Hou, Ming Ming, Long Yu, Amber Seba, Zhijian Qian.   

Abstract

Emerging evidence suggests that adenomatous polyposis coli (Apc) plays a critical role in the maintenance of hematopoietic stem/progenitor cells (HSCs/HPCs). The molecular pathways responsible for the function of Apc in HSCs/HPCs remain unclear. By genetic approach, we demonstrated that inactivation of β-catenin rescued the exhaustion of Apc-deficient HSCs/HPCs, thereby preventing bone marrow failure in Apc-deficient mice. β-catenin loss inhibited the excessive proliferation and apoptosis of Apc-deficient HSCs/HPCs, as well as their defects in myeloid and erythroid differentiation. In addition, loss of β-catenin reversed the down-regulation of Cdkn1a, Cdkn1b, and Mcl1 induced by Apc ablation in Lin(-)Sca(+)c-Kit(+). In assays of long-term stem cell function, the HSCs with deficiency of both Apc and β-catenin displayed a significantly enhanced self-renewal capacity compared with β-catenin-deficient and control HSCs. Our findings suggest that Apc regulates the survival, proliferation, and differentiation of HSCs/HPCs largely through a β-catenin-mediated pathway. They also indicate that multiple downstream targets of Apc including β-catenin may coordinately regulate HSC self-renewal.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547052      PMCID: PMC3656446          DOI: 10.1182/blood-2012-12-473470

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase.

Authors:  T Ishidate; A Matsumine; K Toyoshima; T Akiyama
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

2.  Activation of Wnt/β-catenin protein signaling induces mitochondria-mediated apoptosis in hematopoietic progenitor cells.

Authors:  Ming Ming; Sheng Wang; Wenshu Wu; Vitalyi Senyuk; Michelle M Le Beau; Giuseppina Nucifora; Zhijian Qian
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

3.  Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene.

Authors:  Sumitaka Hasegawa; Tomoyuki Sato; Hiroshi Akazawa; Hitoshi Okada; Akiteru Maeno; Masaki Ito; Yoshinobu Sugitani; Hiroyuki Shibata; Jun-ichi Miyazaki Ji; Motoya Katsuki; Yasutaka Yamauchi; Ken-ichi Yamamura Ki; Shigeru Katamine; Tetsuo Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.

Authors:  Menno F Kielman; Maaret Rindapää; Claudia Gaspar; Nicole van Poppel; Cor Breukel; Sandra van Leeuwen; Makoto Mark Taketo; Scott Roberts; Ron Smits; Riccardo Fodde
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

6.  Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

Authors:  T Cheng; N Rodrigues; D Dombkowski; S Stier; D T Scadden
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

7.  A role for the Adenomatous Polyposis Coli protein in chromosome segregation.

Authors:  K B Kaplan; A A Burds; J R Swedlow; S S Bekir; P K Sorger; I S Näthke
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

8.  Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome.

Authors:  Yukiko M Yamashita; D Leanne Jones; Margaret T Fuller
Journal:  Science       Date:  2003-09-12       Impact factor: 47.728

9.  The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.

Authors:  Christopher D Heinen; Kathleen Heppner Goss; James R Cornelius; George F Babcock; Erik S Knudsen; Timothy Kowalik; Joanna Groden
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  Beta-catenin is dispensable for hematopoiesis and lymphopoiesis.

Authors:  Monica Cobas; Anne Wilson; Bettina Ernst; Stéphane J C Mancini; H Robson MacDonald; Rolf Kemler; Freddy Radtke
Journal:  J Exp Med       Date:  2004-01-12       Impact factor: 14.307

View more
  9 in total

1.  Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms.

Authors:  Heather A Himburg; Phuong L Doan; Mamle Quarmyne; Xiao Yan; Joshua Sasine; Liman Zhao; Grace V Hancock; Jenny Kan; Katherine A Pohl; Evelyn Tran; Nelson J Chao; Jeffrey R Harris; John P Chute
Journal:  Nat Med       Date:  2016-12-05       Impact factor: 53.440

2.  Extracellular Adenosine (eAdo) - A2B Receptor Axis Inhibits in Nlrp3 Inflammasome-dependent Manner Trafficking of Hematopoietic Stem/progenitor Cells.

Authors:  Arjun Thapa; Ahmed Abdelbaset-Ismail; Vira Chumak; Mateusz Adamiak; Katarzyna Brzezniakiewicz-Janus; Janina Ratajczak; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2022-07-23       Impact factor: 6.692

3.  Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis.

Authors:  Qiqi Lin; Limei Wu; Srinivas Chatla; Fabliha A Chowdhury; Neha Atale; Jonathan Joseph; Wei Du
Journal:  J Clin Invest       Date:  2022-06-15       Impact factor: 19.456

4.  β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).

Authors:  Liping Li; Yue Sheng; Wenshu Li; Chao Hu; Nupur Mittal; Kaoru Tohyama; Amber Seba; You-Yang Zhao; Howard Ozer; Tongyu Zhu; Zhijian Qian
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

5.  High Levels of Canonical Wnt Signaling Lead to Loss of Stemness and Increased Differentiation in Hematopoietic Stem Cells.

Authors:  Farbod Famili; Martijn H Brugman; Erdogan Taskesen; Brigitta E A Naber; Riccardo Fodde; Frank J T Staal
Journal:  Stem Cell Reports       Date:  2016-05-10       Impact factor: 7.765

Review 6.  Therapeutic Vulnerabilities of Transcription Factors in AML.

Authors:  Irum Khan; Elizabeth E Eklund; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2020-11-06       Impact factor: 6.009

7.  Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.

Authors:  W Fiskus; S Sharma; S Saha; B Shah; S G T Devaraj; B Sun; S Horrigan; C Leveque; Y Zu; S Iyer; K N Bhalla
Journal:  Leukemia       Date:  2014-12-08       Impact factor: 11.528

8.  Microtubule plus-end tracking Adenopolyposis Coli negatively regulates proplatelet formation.

Authors:  C Strassel; S Moog; L Mallo; A Eckly; M Freund; C Gachet; F Lanza
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

Review 9.  Cancer Stem Cells, Quo Vadis? The Notch Signaling Pathway in Tumor Initiation and Progression.

Authors:  Christian T Meisel; Cristina Porcheri; Thimios A Mitsiadis
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.